It is the first treatment in the last 30 years that represents a relative improvement of 38% in the overall survival of patients compared to standard treatment. The results of Phase III study ZUMA-7 ...
Read more
These results offer new hope for patients in the early stages of the disease, as they represent the largest reduction in mortality ever recorded in the field of lung cancer and highlight how targeted ...
Read more
Published in The Lancet Oncology results of the multicenter phase II MOUNTAINEER study (1) show that tucatinib plus trastuzumab had clinically meaningful anti-tumor activity and favorable tolerability...
Read more
The key is some very rare mutations in the USP9X protein, which regulates cellular processes critical for tumour growth. Roldán-Romero’s research shows that these mutations override the function of...
Read more
The results of the study led by IDIBELL and the Hospital de Bellvitge solve a pending issue and open new ways to improve the patients’ life quality with safe and effective treatment.
Read more
El trabajo destaca cómo un equipo ha descrito recientemente que, en el hígado, la metformina es capaz de aumentar los niveles de microRNA let-7, una molécula de señalización en varias funciones f...
Read more
The triple effect of obefazimod would make the drug a potential candidate when designing HIV remission strategies
Read more
Beyond the Pill es un término holístico centrada en el paciente donde la salud y bienestar de una persona va más allá de simplemente tomar una píldora o medicamento y engloba la tecnología de la...
Read more
Researcher has been able to verify that the combination of two drugs, enfortumab vedotin and pembrolizumab, which had previously shown benefits in survival in second-line treatment and in cases of adv...
Read more
Un 80% de pacientes con tumores neuroendocrinos responden al tratamiento con Lutatera y se ha comprobado que en muchos casos los tumores reducen su tamaño y en otros se estabilizan y mejoran los sín...
Read more
Aelis Farma announced publication of a series of studies describing a new pharmacological class, cannabinoid receptor 1 signaling-specific inhibitors (CB1-SSi), and its first drug candidate, AEF0117, ...
Read more
The development of future clinical trials to validate and confirm the action of ranolazine in cancer patients will be facilitated by the fact that it has already been approved for use in humans and is...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
